Dual CAR-T cells therapy(Cheetah Cell Therapeutics)

N/A

Report date: 2024/07/22 17:54:24

Base Information

Drug NameDual CAR-T cells therapy(Cheetah Cell Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionNKG2D ligands modulatorsProgrammed cell death protein 1 modulators
TargetsNKG2D ligandsProgrammed cell death protein 1
Therapy Area/IndicationsOvarian NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou CNK Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou CNK Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A